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Staphylococcal carriage, particularly Methicillin-resistant Staphylococcus aureus 
(MRSA), is a risk factor for surgical site infection (SSI).  The purpose of this project was to 
determine whether adult patients undergoing total hip and total knee arthroplasty could be 
successfully decolonized of MRSA beginning on the day of surgery, and if decolonization would 
reduce surgical site infection (SSI) rates. 
The study employed two theoretical frameworks:  Nola Pender’s Health Promotion 
Model and Kurt Lewin’s Change Theory.  The sample consisted of 50 patients, 10 cases and 40 
controls, selected from a convenience sample of 299 patients who underwent total hip or total 
knee arthroplasty from May 1, 2012 to May 1, 2013 at a large Midwestern teaching hospital.  A 
case-control study design was utilized.  Data was collected using retrospective chart review. 
Characteristics of cases and controls were compared on categorical variables using Chi-
square statistics.  Fisher Exact tests were used when expected cell frequencies were less than 5.  
For continuous variables, independent group t-tests were used for comparisons.  Evaluation of 
change in infection rates pre to post surgery was done using the Wilcoxon test.  The small 
sample size precluded meaningful inferential statistical tests related to these variables. 
MRSA colonization in the cases was reduced from 100% to 30% (7/10) pre to post 
surgery in the case patients.  No prediction can be made about reducing SSI related to the limited 
sample size.  A multisite study is recommended to address this limitation.   
This pilot project suggests that screening for existing nasal MRSA and beginning 
decolonization on the day of surgery for patients undergoing THA or TKA surgery may 
effectively result in temporary decolonization during the perioperative period and may 
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Background and Significance of the Project 
 Patients colonized with methicillin-resistant Staphylococcus aureus (MRSA) who are 
planning to undergo total hip or total knee arthroplasty may be at greater risk for acquiring a 
surgical site infection (SSI).  The National Healthcare Safety Network (NHSN) at the Centers for 
Disease Control and Prevention (CDC) reports that MRSA has been found to be a pathogen in 
SSIs and other complications that can occur during the post-operative period (Hidron et al., 
2008).  Surgical site infections result in prolonged hospital stays, readmissions and increased 
mortality rates (Anderson & Kaye, 2009; Gupta, Strymish, Abi-Hadar, Williams, & Itani, 2011; 
Whitehouse, Friedman, Kirkland, Richardson, & Sexton, 2002).  Such adverse health outcomes 
unfavorably affect patient safety and impact the rising costs of health care.   
Anderson and Kaye (2009), report that S. aureus is the most frequent causative agent of 
SSIs.  Staphylococcus aureus resistance to antibiotics is growing.  Jernigan (2004, p. 458), of the 
CDC, stated:  
Data from National Nosocomial Infections Surveillance (NNIS) System hospitals 
reported between 1992 and 2002 show that among SSIs following CABG, 
cholecystectomy, colectomy, and total hip replacement, the overall proportion caused by 
S. aureus increased from 16.6% to 30.9%; the proportion of S. aureus infections 
attributable to MRSA increased from 9.2% to 49.3% (Centers for Disease Control and 
Prevention, National Nosocomial Infection Surveillance [NNIS] System, unpublished 
data, May 5, 2004).  
  
The increase in MRSA is a factor impacting quality medical care.   
Up to 15 million operations are performed each year in the United States (U.S.) alone 
(Anderson & Kaye, 2009).  According to the Society for Healthcare Epidemiology in America 
(SHEA)/Infectious Diseases Society of America (IDSA) Practice Recommendations, “SSIs occur 
in 2%-5% of patients having inpatient surgery in the U.S., and approximately 500,000 SSIs occur 




annually” (Anderson et al., 2008, p.1).  SSIs increase morbidity and mortality in surgical 
patients.  Hospital length of stay can be increased by 7-10 days related to SSIs, and if one has an 
SSI the risk of death increases 2-11 times when compared to that of a patient without an SSI 
(Anderson et al., 2008).  Studies suggest that from an economic perspective, preoperative 
screening and decolonization of patients undergoing orthopedic surgery is a simple and cost-
effective patient safety measure that may reduce the risk of SSI, while saving money for 
hospitals and third-party payers (Courville et al., 2012; Lee et al., 2010). 
This paper describes a pilot project in a large teaching hospital system in the Midwest.  
Currently the nares of all patients in this facility are screened for MRSA on admission, transfer, 
discharge and death.  Admission swabs are analyzed by polymerase chain reaction (PCR) and 
results are available within one hour.  Given the availability of admission MRSA screening 
results, the Orthopedic surgery group believed preoperative MRSA decolonization might be a 
strategy to consider to further decrease their already low SSI rate in total hip arthroplasty (THA) 
and total knee arthroplasty (TKA) patients.  An infection preventionist, orthopedic surgeon, and 
the hospital epidemiologist were interested in adding MRSA decolonization to the perioperative 
routine which would change the standard of care for THA and TKA surgeries at this facility by 
temporarily decolonizing patients and possibly reduce the risk of a MRSA SSI.   
A proposal for a systems change project (SCP) to implement decolonization of patients 
undergoing total hip and total knee surgery at the time of surgery was submitted to the health 
facility’s Institutional Review Board (IRB) as well as to the St Catherine University IRB, and 
was approved.  The goal of the project was to implement MRSA decolonization at the time of 
surgery in adult patients undergoing total hip or total knee arthroplasty, who were known or 
newly screened positive, and to determine what proportion of these patients could be temporarily 




decolonized.  It was further hypothesized that temporary decolonization might reduce SSIs when 
compared to the standard of care at the facility, which at the time the project was proposed was 
no decolonization at all.   
Quality improvement could be measured and evaluated by implementing such a project.  
Patients colonized with MRSA would receive a more appropriate prophylactic antibiotic and 
may be temporarily decolonized during the perioperative and immediate postoperative period, 
when the risk of SSI is the greatest.  Decolonization of MRSA positive THA/TKA patients could 
potentially decrease the risk of SSI for this patient population, and decrease the MRSA burden in 
the hospital overall as well.  As noted earlier, the orthopedic subspecialty historically has a low 
SSI rate for clean surgical procedures such as THAs and TKAs.  However, the group indicated 
an interest in reducing the SSI rate even further by using an evidence-based approach and 
implementing decolonization.  
 Decolonization of MRSA positive THA/TKA patients as a project implemented over one 
year as a proposed innovation would require an interdisciplinary approach.  Unit nurses, CRNAs, 
orthopedic physicians, lab and pharmacy were involved.  Communication with all partners would 
be critical, including union involvement related to participation of unit nurses and CRNAs at the 
time of project implementation.  Initial diffusion would occur as the protocol was implemented 
with discussion taking place among the various groups.  Diffusion would continue to occur as the 
results of the project were evaluated and disseminated. 
Project Objectives 
The project objective was to determine the short term success of methicillin-resistant 
MRSA decolonization at the time of surgery for patients undergoing total hip and total knee 
procedures and to determine whether decolonization at the time of surgery is effective in 




reducing the rate of surgical site infection (SSI).   The primary endpoint for this project is to 
identify the proportion of patients undergoing total hip or total knee arthroplasty successfully 
decolonized beginning on the day of surgery.  Positive outcomes for this project will simplify 
and target the management of surgical patients by reducing the risk of MRSA SSIs.  This could 
be significant at the local level and beyond.   
Systems change and principles of social justice.  Access to quality medical care is a 
social justice issue.  Patients should expect quality care that addresses not only physical aspects 
of care but psychological and spiritual aspects as well.  The facility is a regional referral center 
for orthopedic surgeries.  Patients may be referred from other Midwestern states.  Many of the 
patients scheduled for these procedures are aging individuals, without other health care coverage.  
A decolonization procedure would decrease the risk of MRSA SSIs for individuals having 
surgeries that require orthopedic implants. This intervention will not change accessibility for 
patients.  It may minimize the risk of SSI which will improve the quality of care, health 
outcomes and contribute to patient satisfaction.  It is socially responsible to provide this service 
for this group of patients.      
Beyond the physical signs and symptoms, acquisition of a MRSA infection can have an 
undesirable psychological effect on patients and families as isolation will be required.  Isolation 
precautions not only sequester the patient, they may reduce the frequency and duration of 
encounters between patients and their health care providers (Kirkland, 2009).  If healthcare 
facilities have a high prevalence of MRSA, a decolonization procedure may decrease the risk of 
MRSA SSIs for surgical patients that require orthopedic implants.  If successful, decolonization 
will improve the quality of care, health outcomes and contribute to patient and family 




satisfaction by reducing the burden of MRSA in a hospital.  It is socially responsible to attempt 
MRSA preoperative nasal decolonization. 
Social justice, racial disparity, and joint replacement surgery.  An additional aspect 
of TKA surgery related to social justice is that of racial disparity.  A Healthy People 2010 
objective called for eliminating racial disparities in the rate of total knee replacement among 
persons ≥ 65 years (CDC, 2009, p. 133).  This disparity was not explained by varying risk for 
knee osteoarthritis.  The CDC indicated disparate access to health care probably did not explain 
the disparity.  It was further stated “Several reports have indicated that racial disparity in Total 
Knee Replacements (TKR) procedures persists even after adjusting for access to clinical care” 
(CDC, 2009, p. 137).  Non-white Medicare beneficiaries are more likely to have the procedure at 
a hospital that performs fewer TKRs per year and where adverse outcomes are more common 
(CDC, 2009). 
 According to research by Ibrahim, Siminoff, Burant and Kwoh (2002), African-American 
patients had more concerns about postoperative pain and ambulation than whites.  The authors 
also found joint replacement itself to be less well known to African-Americans.  Similar to the 
findings in the CDC article, disparities were found related to knowledge and what to expect after 
surgery.    
Differences in knowledge, attitudes and beliefs regarding TKR may have an influence on   
this disparity.  Low outcome expectations as a result of communication gaps with health care 
providers or inaccurate information from peers may have an effect.  Culturally sensitive 
educational resources must be developed and available for providers and their patients so this 
health disparity can be overcome. 




As a regional referral site the facility performs a higher volume of joint replacement 
surgeries, and already demonstrates low infection rates without MRSA decolonization.  While 
temporary decolonization may decrease the risk of infection during the perioperative period, this 
action in and of itself will not address racial disparity and joint replacement.  As stated above, 
providers must have an awareness of and be culturally sensitive when discussing this topic with 
African-American patients. 
Social justice and Catholic teachings.  The U.S. Conference of Catholic Bishops 
(USCCB) offered this “Pastoral Reflection on Lay Discipleship for Justice in a New Millennium 
1998:   
Catholicism does not call us to abandon the world, but to help shape it. This does not 
mean leaving worldly tasks and responsibilities, but transforming them. Catholics are 
everywhere in this society. We are corporate executives and migrant farm workers, 
senators and welfare recipients, university presidents and day care workers, tradesmen 
and farmers, office and factory workers, union leaders and small business owners. Our 
entire community of faith must help Catholics to be instruments of God's grace and 
creative power in business and politics, factories and offices, in homes and schools and in 
all the events of daily life. Social justice and the common good are built up or torn down 
day by day in the countless decisions and choices we make. This vocation to pursue 
justice is not simply an individual task -- it is a call to work with others to humanize and 
shape the institutions that touch so many people. The lay vocation for justice cannot be 
carried forward alone, but only as members of a community called to be the "leaven" of 
the Gospel. (2013, paragraph 10).   
 
We are invited to expand and grow social justice in organizations from the inside through 
systems change. 
The Joint Commission (2010), a hospital accreditation organization, developed the 
monograph:  Advancing Effective Communication, Cultural Competence, and Patient-and 
Family-Centered Care:  A Roadmap for Hospitals.  This document is designed to assist hospitals 
in meeting the particular needs of each patient regarding language, culture, health literacy, other 
communication barriers, mobility needs and concerns of lesbian, gay, bisexual and transgender 




populations (Joint Commission, 2010).  Practice examples are included in addition to 
recommendations, with chapters identifying these specific points along the continuum of care:  
admission, assessment, treatment, end-of-life care, discharge and transfer, and organization 
readiness (Joint Commission, 2010).  The important theme of patient centered care is supported 
throughout this monograph from the perspective of social justice. 
Conclusion.  This project addresses the responsibility of pursuing social justice.  
Decolonization may prevent infection and further complications, even death, that could result 
from a SSI.  Implementing decolonization may increase the likelihood of a quality health 
outcome that will impact psychological, spiritual, and physical aspects of care for patients.  
Quality health outcomes not only contribute to patient satisfaction, but affect the psychological, 
spiritual and physical well-being of family members who are instrumental in supporting the 
patient at the time of surgery as well.     
 






This chapter will discuss two models that were selected to support the project as a 
theoretical framework.  One model is grounded in the field of social and behavioral science, and 
was chosen as an approach to encourage and sustain staff from the various disciplines to 
participate fully in the project (Kurt Lewin’s Change Theory).  The second model supports 
preventive health behaviors and was selected to motivate and positively influence patients to 
complete the decolonization process following discharge from the hospital (Nola Pender’s 
Health Promotion Model).   
The chapter will further address the clinical questions in PICO design (patient population, 
intervention, comparison group, and outcome) that formulated the basis of the project.  A review 
and synthesis of literature that is relevant to MRSA decolonization, orthopedic surgery, surgical 
site infection and total hip/total knee arthroplasty is included in the chapter as well.  
 A theoretical framework provides guidance as a project evolves.  The end results will 
determine whether the knowledge learned from implementing a project should create a change in 
practice (Sinclair, 2007).   The theoretical framework of this project relies on Nola Pender’s 
Health Promotion Model (HPM) and Kurt Lewin’s Change Theory.  Both theories are applicable 
to the project, one relative to the patients and one to the health care workers.  Pender’s model 
will directly affect the patient participation component of MRSA decolonization.  Lewin’s model 
will be utilized to facilitate the change in work practices for health care workers.  It is necessary 
for both groups to engage in this project if the goal of temporary MRSA decolonization and 
prevention of SSIs will be achieved.   




In the Health Promotion Model (HPM), Pender contends that nurses can assist people to 
care for themselves and achieve self-efficacy (1996).  Nurses can accomplish this by recognizing 
the complex biological and psychosocial processes that motivate people to participate in 
behaviors that will improve health (Pender, 1996).  A diagram of Pender’s model (Appendix A) 
flows from left to right, structured in three columns or pillars representing individual 
characteristics and experiences, behavior specific cognitions and affect, and behavioral outcomes 
(Pender, 1996).   
Pender’s model has fourteen assertions. Two of the assertions in particular apply to this 
project.  One is that “persons commit to engaging in behaviors from which they anticipate 
deriving personally valued benefits” (as cited in Sakraida, 2002, p. 630).  A second assertion is 
that “perceived competence or self-efficacy to execute a given behavior increases the likelihood 
of commitment to action and actual performance of the behavior” (as cited in Sakraida, 2002, p. 
630).  Applying mupirocin to one’s nares to decolonize MRSA in the postoperative period which 
will be required of participant’s in this systems change project demonstrates an individual’s 
commitment to a plan of action and health promoting behavior.  The positive health outcome will 
be temporary MRSA decolonization and possible prevention of a MRSA SSI. 
Kurt Levin’s Change Theory (Nursing Theories, 2011) is a second theoretical framework 
applied to this SCP.  Burnes (2004) asserts that although Lewin developed this three-step model 
over 60 years ago, it continues to be a commonly cited framework to support successful change 
projects.  The three steps are unfreezing, moving and refreezing.  Lewin determined in Step 1, 
unfreezing, that human behavior is held in equilibrium by driving and restraining forces.  He 
believed this equilibrium needs to be disrupted in order for change to occur (Burnes, 2004).  Old 




behaviors would need to be rejected and replaced by new, thus his use of the term unfreezing 
(Burnes, 2004; Medley & Akan, 2008). 
Step 2 or moving, involves learning.  Learning includes knowledge of what the possible 
options are and moving on from previous behaviors to new behaviors which will enable the 
planned change to occur.  Assessment and reinforcement are necessary during this step, or it is 
possible that the change may be temporary (Burnes, 2004; Medley & Akan, 2008). 
 In Refreezing or Step 3 the new equilibrium is established.  New behaviors are sustained 
and it is posited that old behavior will be unlikely to be resumed (Burnes, 2004).  It would be 
expected that innovative work practices would be fully implemented as part of a system change 
project during this step in the change process (Medley & Akan, 2008).   
Lewin’s model is relevant to this system’s change project in several ways.  Unit nurses 
will be responsible for identifying on the lab request that a patient is being admitted for a THA or 
TKA.  When a patient’s admission MRSA swab is positive the CRNA will be responsible for 
notifying the surgeon to order vancomycin rather than cefazolin, and in addition to order 
mupirocin to begin decolonization.  Applying Lewin’s model may assist in promoting 
acceptance of these changes and limit resistance from the health care providers. 
Literature Review and Synthesis 
Prior to beginning the literature review two PICO questions were formulated.  The first 
PICO question associated with this literature review was:  In adult patients undergoing total hip 
and total knee arthroplasty, what proportion of MRSA positive patients can be temporarily 
decolonized when compared to the standard of care (no decolonization)?  A second PICO 
question associated with this literature review was:  In adult patients undergoing total hip and 




total knee arthroplasty, does decolonization of MRSA positive patients reduce surgical site 
infection when compared to the standard of care (no decolonization)? 
Database Search/Articles Selected 
The National Library of Medicine Medical Subjects Headings (MeSH) browser was used 
to review and to relate chosen descriptor words.  Key search terms included:  MRSA, 
decolonization, orthopedic surgery, surgical site infection and total joint arthroplasty.  The 
databases utilized for journal searches from 2007-2012, were CINAHL and PubMed.  Articles 
selected were from peer reviewed journals.  Limiters such as evidence based practice, English 
only, human subjects, gender all, and adult age groupings were applied.  Randomized controlled 
trials (RCTs) and cohort studies were preferred for offering evidence-based practice.  Cohort 
studies were prevalent in the search and selected because the study designs and the findings 
identified were comparable to the PICO question.  Although review articles were included in the 
search and were examined, they will not be incorporated into this paper.  Exclusion criteria were 
books/texts, and articles with heavy emphases on clinical microbiology, specific prosthetics, and 
other MRSA related post-operative complications.  Articles selected for this literature review are 
included in the Table 1 (Appendix B).           
Critical Analysis of Evidence Related to the Clinical Question 
Literature or articles.  Overall the articles examine the impact of MRSA decolonization 
on outcomes of patient care. More specific categorization identifies three subgroups:  patients 
screened for MRSA decolonization with the hypothesis that this would decrease SSI rates (Kim 
et al.,  2010; Hadley, Immerman, Hutzler, Slover, & Bosco, 2010; Price et al., 2008); screening 
and factors associated with poor post-operative outcomes (Gupta, Strymish, Abi-Haidar, 
Williams, & Itani, 2011; Yano et al., 2009); and factors influencing failure to decolonize 




(Buehlmann et al., 2008; Lee et al., 2011).  The primary objective of Price et al. (2008) was to 
determine the prevalence of nasal colonization with S. aureus.  Prevalence, an important factor in 
decision-making about per-screening and decolonization, was quantified in another of the earlier 
articles (Buehlmann et al., 2008) and one of the most recent (Lee et al., 2011).  Knowledge about 
prevalence influences positive patient outcomes and can impact resource utilization. 
Population/sample.  Patients sampled in five of the seven studies included preoperative 
patients scheduled for elective surgery (Kim et al., 2010; Gupta et al., 2011; Yano et al., 2009; 
Hadley et al., 2010; Price et al., 2008).  Four of the five studies focused on orthopedic patients.  
Gupta et al. (2011) included all surgical subspecialties at a Veterans Affairs hospital except 
dental and ophthalmology.  The patients sampled in the remaining two studies included 
hospitalized patients, not necessarily scheduled for surgery.  All studies used a convenience 
sample of consecutive patients.  Only Gupta et al. (2011) described the patients selected as 
having clean or clean-contaminated wound classes.  The other authors may have assumed 
common knowledge that most index orthopedic procedures are clean cases.  Wound 
classification is an important defining term for all surgical subspecialties.  Clean and clean-
contaminated wound classifications are not considered a risk factor for SSI (Mangram, Horan, 
Pearson, Silver, & Jarvis, 1999).    
Research designs.  Four of the studies utilized a prospective cohort study design (Kim et 
al., 2010; Yano et al., 2009; Hadley et al., 2010; Buehlmann et al., 2008), one (Gupta et al., 
2011) a retrospective design, one a case control design (Lee et al., 2011) and one a cross-
sectional design (Price et al., 2008).  Kim et al. (2010) used historical controls.  Five of the 
studies occurred in hospital setting (Kim et al., 2010; Gupta et al., 2011; Hadley et al., 2010; 
Buehlmann et al., 2008; Lee et al., 2011).  Yano et al. (2009) and Price et al. (2008) screened 




patients in the community setting during pre-operative outpatient clinic appointments.  While 
this strategy is useful for identifying community trends, patient characteristics may not be similar 
to those in the hospital setting.     
Interventions.  Three of the seven studies reviewed included an intervention (Kim et al., 
2010; Hadley et al., 2010; Buehlmann et al., 2008).  All interventions included 2% mupirocin 
ointment to the nares BID x 5 days.  Kim et al. (2010) added 2% CHG showers x 5 days, and 
Hadley et al. (2010) a single CHG (2% or 4% not specified) shower on the day of surgery.  The 
most comprehensive/complex intervention by Buehlmann et al. (2008) included 2% mupirocin to 
the nares BID x 5 days, oral rinsing with 2% CHG TID, daily body washing with 4% CHG, and 
oral antimicrobials once or twice daily depending on the site for urogenital and gastrointestinal 
decolonization.  Perioperative vancomycin was used by Kim et al. (2010) and Hadley et al. 
(2010) for better MRSA coverage rather than cefazolin.  Vancomycin was given perioperatively 
in some of the cases analyzed by Gupta et al. (2011).  The type of case was not detailed but was 
adjusted for in the analysis.  Buehlmann et al. (2008) ordered oral vancomycin for patients 
requiring gastrointestinal decolonization.  This study did not focus on surgical patients, but 
hospital patients overall. 
 Comparisons.  Only two of the seven studies used a case-control design so comparison 
was not possible.  Kim et al. (2010) utilized a historical control group for comparison that 
immediately preceded the study group.  This close temporal association may have reduced 
confounding that occurs with historical controls related to changing demographic characteristics 
over time.   Hadley et al. (2010) identified a control group by selecting those patients who did 
not participate in MRSA screening before surgery.  This may influence results.  Bias exists 
because these patients self-selected out of the opportunity for screening.  Kim et al. (2010) 




compared SSI rates between carriers and non-carriers during the study period, giving some 
insight into the non-intervention, non-historical control subjects in the study group, rather than 
only comparing with the historical controls.  All participants in the study were matched by age 
and gender.  Buehlmann et al. (2008) compared the proportion of patients positive on admission 
to those positive following decolonization.  There was no control group.  Without a control 
group the results may have been influenced by extraneous variables.  Lee et al. (2011) compared 
characteristics of the cases to controls to determine factors influencing persistent MRSA 
colonization related to mupirocin and CHG use.   
Outcome Measures.  Decolonization of patients who were MRSA positive on admission 
and the effect on SSI rates was described in five of the studies (Kim et al., 2010; Gupta et al., 
2011; Yano et al., 2009; Hadley et al., 2010; Price et al., 2008).  In each of these studies SSIs 
were determined using the standard National Healthcare Safety Network (NHSN) surveillance 
definitions.  These definitions limit an SSI to within 30 days past surgery, or up to one year from 
surgery if the case involved an implant.  In addition, the definitions determine the depth of the 
infection:  superficial, deep, or organ/space.  A superficial infection cannot occur after 30 days 
from the day of surgery.  
 Carrier status following decolonization was an outcome measure included in three of the 
studies (Kim et al., 2010; Buehlmann et al., 2008; Lee et al., 2011).  Age, previous 
hospitalization, and antimicrobial use were some of the variables associated with persistent 
colonization.  Age is also a factor associated with the need for joint implant surgery.  The risk of 
an SSI may be reduced for an older person having joint replacement surgery if decolonization is 
successful in the presence of these variables.  Buhlmann et al. (2008) reported decolonization 
was “highly effective” when patients completed the entire course of treatment.  Completion of 




decolonization treatment may be more easily accomplished within the hospital setting where it is 
essentially a directly observed therapy.    
Results.  There was a significant decrease in SSI rates with decolonization in the studies 
conducted by Kim et al. (2010), Gupta et al. (2011) and Hadley et al. (2010).  Kim et al. (2010) 
found the SSI rate during study period lower than in control period (59% reduction rate, 
p=0.009).  Gupta et al. (2011) found a positive pre-op MRSA culture significant for positive 
post-op culture (p<0.001), for a MRSA SSI (p=0.01), and for other post-op infections (p<0.01) 
unadjusted.  Yano et al. (2009) found one is 11 times more likely to have an MRSA SSI if 
prescreening was positive (adjusted OR 11.0, 95% CI (3.0-37), p<0.001).   Lee et al. (2011) 
found age, combined mupirocin and CHG resistance, hospitalization within two years, 
wounds/ulcers, MRSA inactive antibiotic use, and central lines to be independent risk factors 
associated with persistent colonization and decolonization failure.  The study by Price et al. 
(2008) revealed 30.3% subjects (86/284) to be colonized with S. aureus, five of which were 
MRSA (6%).  Of the 284 patients screened in two years, 1.8% were colonized with MRSA.  
Buehlmann et al. (2008) found decolonization completed in 87% (54/62) patients with a mean of 
2.1 and a SD±1.8. 
 Validity is a question in the study by Hadley et al. (2010).  From the results section 
(Hadley et al., 2010, p.2) in the article:   
During the study period, 2058 patients were included in the study.  There was complete 
follow-up in this retrospective study of prospectively collected data.  The total number of 
treatment patients was 1644 patients (80%) and 414 (20%) in the control group.  At the 
onset of the study the proportion of the preadmission testing (PAT) treatment group was 
roughly equal.  However as the study progressed the protocol was quickly adopted by all 
surgeons and the non-PAT patients decreased significantly. 
 
The treatment group had approximately four times the number of patients as the control group.  
Only deep SSIs were reported in the outcome data, superficial and organ/space (joint) infections 




were not.  The reported 13% decrease in deep SSIs in the treatment group versus the control 
group was not significant at the reported p value of 0.809, but does represent a favorable trend.  
There was no discussion about adjusting statistically for the confounder of surgeons adopting the 
protocol outside of the study parameters.   
Synthesis of the Evidence Related to the Clinical Question. 
 These studies have clinical significance because MRSA decolonization in adult patients 
undergoing total hip and total knee arthroplasty may reduce SSIs when compared to the standard 
of care.  Decolonization has not been recommended in the past except in outbreak situations or 
for use with specific populations, in this case adults scheduled for elective joint replacement.   
 The articles assembled in the literature review contain evidence suggesting that 
prescreening and eradication of nasal MRSA is a practical action to consider.  It has been 
previously stated that SSIs increase morbidity and mortality.  Yet, SSIs are preventable and one 
approach may be prescreening and decolonization.  All articles that discussed decolonization 
favored it.  Five of the seven articles reviewed were specifically written to address 
decolonization and SSI prevention in patients scheduled for orthopedic surgery.  Completing the 
full treatment course was noted to make decolonization “highly effective” by Buehlmann et al. 
(2008, p. 501), although the article was not written related to orthopedic surgery, but to overall 
hospital admits.   
 The study by Lee et al. (2011) cautioned against widespread use of the antimicrobial and 
skin disinfectants.  The authors found resistance to those products significantly increased the risk 
for persistent nasal MRSA colonization following treatment to eradicate it.  It is noted in the 
article that the study site had been using mupirocin and CHG to decolonize patients since 1994 
(Lee et al., 2011, p. 1423).  Antimicrobial stewardship is a large part of the mission of the 




Infectious Disease Section and an Antimicrobial Subcommittee at the facility where the project 
was implemented.  Decolonization and resistance always merits close monitoring. 
 In spite of the inconsistencies noted above there is sufficient evidence in the literature 
reviewed for this paper to attempt prescreening and decolonization for adult patients undergoing 
total hip and total knee arthroplasty.  Prescreening and decolonization can be an effective 
prevention strategy that may be adopted as a change in institutional protocol, and thus a change 
in a system in the population served by this project.  Surgeries involving implants are high risk 
surgeries.  Surveillance cultures for MRSA are collected on admission, transfer, discharge and 
death under an existing directive at this facility.  Decolonization and monitoring of infection is 
more easily done because of this.  MRSA decolonization as a part of a pre-operative protocol 
could increase positive post-operative outcomes and assist in decreasing the MRSA burden 
hospital wide. 
Additional Evidence 
 National practice guideline review.  The National Guideline Clearinghouse, Cochrane 
Reviews, and the Association of Professionals in Epidemiology and Infection Control (APIC) 
were accessed online in the search process.  Search terms used included MRSA infection and 
preventing surgical site infection as topics or diseases.  Three related documents were found:  
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of 
Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children (Liu et al., 2011), 
Guide to the Elimination of Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission 
in Hospital Settings (APIC, 2010), and the Guide to the Elimination of Orthopedic Surgical Site 
Infections (APIC, 2010).  Guideline documents selected for this literature review are included in 
the attached Table 2 (Appendix C).           




 The Guide to the Elimination of Methicillin-resistant Staphylococcus aureus (MRSA) 
Transmission in Hospital Settings (APIC, 2010) addressed nasal decolonization.  Decolonization 
is not routinely recommended; but indicated for certain situations such as in an outbreak setting, 
or to eradicate carriage in patients with recurrent infections, and in colonized MRSA patients 
undergoing a surgical procedure identified as high risk for a MRSA SSI (APIC, 2010).  
Decolonization was described as: 
The use of a variation of the following regimen for adults:  Nasal decolonization with 2% 
mupirocin ointment applied to the nares twice a day for five days; AND, Skin antisepsis 
with chlorhexidine or hexachlorophene for 5 days applied per manufacturer’s instructions 
(APIC, 2010, p. 62).   
 
 The document reports decolonization may be indicated for patients undergoing surgeries 
with implants including cardiac, orthopedic, vascular and neurosurgical procedures (APIC, 
2010). 
 The Guide to Elimination of Orthopedic Surgical Site Infections (APIC, 2010) reports, 
“Staphylococcus aureus, particularly MRSA, remains a significant pathogen in postoperative 
orthopedic SSIs (APIC, 2010, p. 39).  Decolonization is discussed as an option for orthopedic 
surgery patients.  The authors urge that decolonization strategies and protocols be standardized, 
and suggest order sets and pathways as two potential ways of achieving this end (APIC, 2010). 
 The Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) 
for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and 
Children (Liu et al., 2011) is an evidence-based guideline providing recommendations for 
management of MRSA infections in adult and pediatric patients.  Multiple clinical syndromes are 
discussed including bone and joint infections.  Decolonization was not addressed related to 
management of bone and joint infections.  It was discussed concerning skin and soft tissues 
infection.  The authors report an association between mupirocin and a decrease in hospital-




acquired S. aureus infections in patients undergoing surgical procedures or receiving dialysis 
(Liu et al., 2011).  The guideline lists recommendations for decolonization followed by a 
summary of the evidence. 
 The IDSA guideline was appraised using the AGREE II online tool (Brouwers et al., 
2010) [Appendix D].  The document is succinct with clearly written definitions, and based on 
evidence of best practice.  A standard procedure was used by the IDSA panel to grade the 
recommendations and weigh the quality of evidence used in the development of the guideline.  
There was an external peer review of the draft document which was reviewed and approved by 
multiple professional organizations These steps contribute to the validity and reliability of the 
document and it’s applicability to the practice setting.  Options and alternative treatments are 
discussed demonstrating clinical flexibility.   
 There are some limitations to the IDSA guidelines.  Although the domain of Rigour of 
Development received the highest score at 46 points, PubMed was the only computerized 
database searched for literature and the search was limited to English-language only.  The 
domain Stakeholder Involvement scored the lowest at 11 points.  Patients and providers are 
identified as the target population however no statement is included as to whether the views and 
preferences of patients/public were considered while the document was being developed.  It is 
unclear whether multiple disciplines were involved in developing the document as the author’s 
titles are not identified.  No plans were offered for future review and update.    
 This guideline is recommended for providers.  Guideline sections begin with a clinical 
practice question followed by graded recommendations and a weighted quality rating.  A 
summary of recent evidence supporting the recommendation completes the discussion of each 
question.  Clinical applicability and patient-centered care are addressed throughout the 




document.  There is also a statement about voluntary adherence to the guidelines.  Providers are 
encouraged to consider individual patients and specific clinical situations, recognizing that this 
guideline is not the only option for providing quality patient care.  Further, antimicrobial use is 
not the only intervention that is recommended.  Prevention education messages about personal 
hygiene and wound care are included as suggested strategies.  There is discussion about not 
sharing or reusing personal items.  Environmental hygiene measures are also described as 
effective interventions for patients.  At the close of the document a section on Research Gaps 
examines areas of limited or conflicting data, and the need for additional research on certain 
topics.  The guideline is worth referencing when managing MRSA infections in adults and 
children.  It is valid, reliable and applicable to many practice settings. 
 Systematic reviews.  Two systematic reviews will be addressed in this section:  
(McGinigle, Gourlay, & Buchanan, 2008; van Rijen, Bonten & Kluytmans, 2008).  These are 
included in Table 3 (Appendix E).  McGinigle et al. (2008), found evidence from several studies 
that collecting ASCs decreases the incidence of MRSA infection.  However, the authors 
concluded that the evidence was of poor quality and reported no definitive clinical 
recommendations could be made.   
 The objective of a review by van Rijen et al. (2011) was to determine whether the use of 
mupirocin nasal ointment in patients identified with S. aureus nasal carriage reduced S. aureus 
infection rates.  In this review an extensive literature search focused on RCTs regardless of 
language or publication status (Table 3, Appendix E).  Nine RCTs were selected.  Patient 
population, interventions and outcomes are described in detail.  Seven of the nine studies were 
double-blind RCTs with four of the seven rated high quality for including blinding, intention-to-
treat, and report of loss to follow-up in addition to the double-blind.  Bias was well controlled for 




in the study designs.  The use of mupirocin in nasal carriers resulted in a statistically significant 
decrease in S. aureus infections (van Rijen et al., 2008).  Two studies were deemed low quality.  
Outcomes were examined individually and combined across the studies when appropriate (Table 
3, Appendix E).   Applicability to clinical practice is articulated throughout this article, most 
strongly in the authors’ conclusions.  Their conclusions were reported as implications for 
practice and implications for research.  The practice implications concluded by the reviewers are 
that in confirmed nasal carriers, mupirocin use should be considered in hospitalized patients 
undergoing surgery or dialysis, and that limited use of mupirocin does not appear to be 
associated with antimicrobial resistance (van Rijen et al., 2008).  The research implication 
gleaned from this systematic review is that the effectiveness of mupirocin is related to carriers 
alone.  Rapid tests to confirm and differentiate MRSA and Methicillin-Sensitive S. aureus 
(MSSA) were discussed.  These important diagnostic tools will enable providers to treat carriers 
in real time, within hours as opposed to days using standard culture technique.  Rapid tests also 
influence proper antibiotic selection for patients (van Rijen et al., 2008). 
 Ranking and type/level of evidence.  Three clinical guidelines, two systematic reviews 
and three original research articles were ranked by level of evidence and quality.  Level of 
evidence criteria are taken from Melnyk & Finehout-Overholt (2011, p.12), and are listed below 
Table 4 (Appendix F).  Criteria used to assess quality are derived from the United States 
Preventive Services Task Force  (2008) which are also noted in Appendix F. 
 All documents examined MRSA colonization in one or more of four ways:  identification 
(screening), preventing, treating and eliminating (decolonizing).  Discussion of decolonization 
was common to all articles.  While none of the authors supported routine decolonization, all 
discussed it as part of an intervention program.  Intervention programs are indicated for MRSA 




outbreaks or for certain at-risk populations (APIC, 2010; APIC, 2010; Liu et al., 2011, van Rijen 
et al., 2008).  The strength of the evidence for pre-screening and decolonization is low to 
moderate and of fair quality (Table 1, Appendix B; Table 2 Appendix C; Table 3, Appendix E).  
In part this is related to the lack of RCTs, a standardized decolonization protocol, concerns about 
possible resistance to mupirocin, and lack of outcome data about reduction of infection rates (Liu 
et al., 2011).  Further research is needed to add to the body of evidence and address these 
concerns. 
 Integration of literature review.  MRSA decolonization in adult patients undergoing 
total joint replacement may reduce SSIs.  Recent studies (Kim et al., 2010; Yano et al., 2009; 
Hadley et al., 2010; Price et al., 2008) favor prescreening and decolonization as a preventive 
measure for patients scheduled for orthopedic surgery (Table 1, Appendix B).  According to the 
APIC Guide to the Elimination of Methicillin-resistant Staphylococcus aureus (MRSA) 
Transmission in Hospital Settings (2010, p. 61), “Decolonization regimens may be indicated for 
both nasal MRSA and S. aureus colonization in patients undergoing vascular surgery with 
placement of a graft, total joint arthroplasty, and neurosurgical procedures with implantation of 
hardware as well as other surgical procedures.” 
 The IDSA Clinical Practice Guidelines for the Treatment of Methicillin-Resistant 
Staphylococcus Aureus Infections in Adults and Children do not offer recommendations for 
decolonization related to orthopedic surgery or bone and joint infections, but do for MRSA skin 
and soft tissue infections.  The recommendation suggests decolonization with mupirocin twice 
daily for 5-10 days as a strategy, and that it is offered with education and reminders about 
hygiene (Liu et al., 2011).  It is disappointing that the recommendation has a CIII rating which is 
defined as “poor evidence to support a recommendation for or against use” as the “evidence is 




from opinions of respected authorities based on clinical experience, descriptive studies or reports 
of expert committees” (Liu et al., 2011, p.52).  This is of interest as the literature review and 
analysis section for the IDSA document states:  “There were few randomized clinical trials; 
many recommendations were developed from observational studies or small case series, 
combined with the opinion of expert panel members” (Liu et al., 2011).  The basis for the IDSA 
document is exactly what was identified as not supporting evidence-based practice. 
 In a Cochrane review, van Rijen et al. (2008) concluded that decolonization with 
mupirocin in S.aureus nasal carriers resulted in a significant reduction in S. aureus infections.  
This systematic review also found a significant reduction in infection rates in surgical and 
dialysis patients in a subgroup analysis.  However, when SSIs were analyzed as the primary 
outcome the result was not statistically significant (van Rijen et al., 2008).   
 An additional finding of van Rijen et al. (2008) was that mupirocin resistance should not 
be an issue following short-term intranasal use for surgical or dialysis patients.  Caution is still 
recommended related to this as Lee et al. (2011) reported genotypic CHG resistance alone did 
not predict persistent MRSA carriage.  CHG and mupirocin are often used simultaneously to 
decolonize or eradicate MRSA.  This suggests that a combination of low-level mupirocin and 
CHG resistance may be required to result in failure to eradicate MRSA.  Persistent colonization 
was also discussed by Buehlmann et al. (2008).  This group determined their standard 
decolonization protocol was highly effective when the full treatment course was completed.  
Their treatment regimen was complex, including intranasal mupirocin ointment, CHG mouth 
rinse and CHG full-body washes, all applied for five days (Buehlmann et al., 2008). 
 Researchers continue to investigate MRSA decolonization.  Many favor this approach for 
certain patient populations.  Prescreening and decolonization is a prevention strategy that could 




be easily implemented for orthopedic patients scheduled for total joint replacement.  Reducing 
MRSA SSIs is an important goal.  Decolonization is an intervention to consider. 
 Summary of recommendations from the literature review.  The summary 
recommendation is:  there is sufficient evidence in the literature to implement prescreening and 
decolonization of MRSA in adult patients undergoing joint replacement surgery.  Recent studies 
(Kim et al., 2010; Yano et al., 2009; Hadley et al., 2010; Price et al., 2008) favor prescreening 
and decolonization as a preventive measure for patients scheduled for orthopedic surgery (Table 
1, Appendix B).  Intervention programs are indicated for MRSA outbreaks or for certain at-risk 
populations (APIC, 2010; APIC, 2010; Liu et al., 2011, van Rijen et al., 2008).  A Cochrane 
systematic review and APIC Guideline documents (Table 2, Appendix C) define orthopedic 
surgery patients as at-risk populations for MRSA infection if colonized preoperatively (van Rijen 
et al., 2008; APIC, 2010; APIC, 2010).   
 Implementation of the summary recommendation requires the following steps:  1) 
collection of an admission nares swab to screen for MRSA (Appendix G); 2) the lab notifies the 
anesthesia workroom (Appendix H); 3) appropriate antibiotic prophylaxis is administered 
(vancomycin instead of cefazolin); 4) first dose of mupirocin is administered in the OR; 5) 
postoperative mupirocin and vancomycin are ordered.  Step 1) is required at the facility where 
the project was implemented under an established policy.  Step 2) is referenced in the system 
review by van Rijen et al, “Recent technological advances in rapid diagnostics have provided the 
ability to detect nasal carriage of S. aureus within hours rather than days which makes it possible 
to treat nasal carriers rapidly” (2008, p. 14).  Step 3) is referenced in the Guide to Elimination of 
Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission in Hospital Settings, “The 
use of systemic antimicrobials for MRSA decolonization may be considered by the patient’s 




healthcare provider if deemed clinically appropriate” (APIC, 2010, p.62).  Gupta et al. (2011) 
reported the risk of vancomycin administration preoperatively in nares positive patients was 
protective, but additionally state an association for this subgroup is not conclusive given the wide 
confidence intervals for this variable. 
 Step 4) Successful decolonization beginning on the day of surgery as opposed to five 
days preoperatively is being implemented.  Liu et al. (2011) reported, “While awaiting guidance 
from ongoing clinical trials, the Panel suggests mupirocin alone or a combined strategy of 
mupirocin and topical antiseptics (e.g., chlorhexidine and diluted bleach baths) if decolonization 
is being considered.  The optimal dosage and duration of such regimens is unknown; suggested 
dosages are based on several ongoing clinical trials” (2011, p. 18).  Step 5) is supported by the 
evidence from the literature addressed under Step 3). 
Methicillin-Resistant Staphylococcus aureus SSIs have been identified as a risk to 
patients colonized with MRSA, and planning joint replacement surgery (Kim et al., 2010; Yano 
et al., 2009; Hadley et al., 2010; Price et al., 2008).  This postoperative complication impacts 
health outcomes for patients in terms of morbidity and mortality (Gupta et al., 2011).  
Methicillin-Resistant Staphylococcus aureus SSIs also contribute to increased length of stay and 
rising costs in health care (Anderson et al., 2009).  Decolonization may be an additional strategy 
to make total joint replacement surgery safer for patients.   
Conclusion.  The literature supports a systems change project that will implement a 
program to preoperatively screen the nares of orthopedic patients presenting for joint 
replacement surgery at the facility.  Admission screening will identify the presence of MRSA.  
Those patients with positive results will be decolonized prior to or at the time of surgery, because 
they are at an increased risk of surgical site infections with a permanent implant.  Mupirocin 




ointment will be the drug used for decolonization, and intravenous vancomycin will be the drug 
given as preoperative antibiotic prophylaxis. 





Project Design and Methodology 
 This SCP implemented a program to preoperatively screen the nares of patients 
presenting for TKA or THA surgery at a Midwest teaching hospital.  Screening identified 
whether MRSA colonization was present or not.  Those patients with positive results were 
decolonized at the time of surgery, because they were at an increased risk of SSI as they were 
undergoing surgery for a permanently implanted prosthetic device.  The data was analyzed to 
determine the differences between the two groups.  Cases were compared to controls who 
underwent the same procedure but who were not decolonized for MRSA, to determine whether 
decolonization was a factor in preventing SSIs at 90 days postoperatively. 
 Data handling and record keeping.  A proposal for this project was reviewed and 
approved by the facility IRB.  The St. Catherine University IRB reviewed the facility IRB file 
and granted approval as well.  A waiver for informed consent was obtained from the facility IRB 
as part of the approval process.  Since the project was a retrospective chart review it was not 
possible to contact all the subjects to obtain consent.  Chart review presented a minimal risk of 
loss of confidentiality and an adequate plan was developed to protect identifiers.   
 Compliance with HIPPA regulations was met.  Lists of subjects were coded.  The links 
for the coded lists were maintained in a locked cabinet in a double locked office available only to 
the research team.  Data was entered into a spreadsheet stored on a personal drive on a secure 
computer.  The computer was accessed with a personal identity verification card and password.  
The facility’s firewall and all other security measures applied to the computer.  When data was 
shared with research staff a secure share drive was used.  No conflict of interest was identified 




for anyone on the research team.  When the data collection was completed and entered into the 
spreadsheet, the identifying link to the subjects was destroyed.    
Selection of subjects.  The project was a retrospective case-control study of patients at 
the facility who were MRSA screen positive preoperatively, began decolonization on the day of 
surgery, and underwent total hip or total knee surgery from May 1, 2012 through May 1, 2013.  
Cases were identified from a convenience sample of 299 patients undergoing THA or TKA 
surgery during the same time period.  The controls were selected from patients undergoing THA 
or TKA surgery at the facility from May 1, 2009 through September 1, 2011.  Controls were 
matched by age (+/- three years), gender (M/F), type of procedure (THA/TKA), and location of 
the surgery (right/left side of the body).    Age inclusion criterion for cases and controls was that 
patient be 18 years of age or older.  While randomization of subjects was not directly applied in 
this project, the historical controls were selected from a database that does utilize a 
randomization process. 
 Project intervention.  Admission nares swabs were submitted to the Microbiology lab.  
Analysis was performed utilizing Polymerase Chain Reaction (PCR).  PCR analysis is only 
utilized for admission nares swabs at the facility unless specifically ordered otherwise.  
Specimens were collected using Copan swabs.  The Cepheid GeneXpert® Infinity-80 System is 
the analyzer that will be employed by laboratory staff to determine the results of the nares swabs. 
 Mupirocin ointment was the drug used for decolonization, and intravenous vancomycin 
was the drug given for pre-operative antibiotic prophylaxis.  Mupirocin was applied twice a day 
to the patient’s nares for a total of five days.  The initial dose was applied by a certified 
registered nurse anesthetist (CRNA) in the operating room.  Nursing staff or patients themselves 
applied the mupirocin twice a day for the three days on average that the patient was hospitalized.  




The patients continued applying the mupirocin two times daily for the remaining two days at 
home to complete the total of five days. 
 Observations and definitions.  Chart review was used for data collection.  Data 
collection included demographics, details of antibiotic use, surgery type and conditions, 
laboratory results, comorbidities and type of surgical site infection.  Secure facility approved 
computer access was used to review the electronic medical record.  Patient data were identified 
by a coded number to protect confidentiality.     
  SSIs were identified using definitions and criteria from the CDC NHSN, “Surgical Site 
Infection (SSI) Event” portion of the “Procedure-associated Events” section of the National 
Healthcare Safety Network (NHSN) Manual Patient Safety Component (CDC NHSN, 2013).  
Definitions from the Veterans Affairs Surgical Quality Improvement Project (VASQIP) were 
used with permission as criteria for all other variables (Mark A. Wilson, MD, personal 
communication, July 7, 2012).       
 Subject population for analysis.  The estimate for enrollment size was based on the 
number of total hip and total knee surgeries seen per month in fiscal year 2011.  The projected 
number was predicted to be between 300 and 330 patients.  Case subjects were compared to 
control subjects undergoing the same procedure, but who were not decolonized for MRSA.  The 
study was terminated following the collection and analysis of the data. 
Statistical analysis.  Characteristics of cases and controls were compared on categorical 
variables using Chi-square statistics.  Fisher Exact tests were used when expected cell 
frequencies are less than 5.  For continuous variables, independent group t-tests were be used for 
comparisons.  Evaluation of change in infection rates pre to post surgery was done using the 




Wilcoxon test.  For those cases or controls with colonization pre surgery, Chi-squared tests, and 
logistic regression, when possible, were used to examine predictors of infection postoperatively.   
Introduction of an unforeseen confounder.  A confounding factor was introduced four 
months prior to the completion of the project.  Another study was implemented using the same 
patient population, patients undergoing THAs and TKAs, but with a different intervention.  This 
may have introduced potential for bias, although it is unlikely. 
Evidence-based Project Implementation Plan 
Timeline.  The timeline for the project was May 1, 2012 through May 1, 2013.  Case data 
was collected retrospectively following those dates using chart review for known MRSA positive 
or patients positive for MRSA on admission and undergoing THA or TKA surgery during that 
period of time.  Control data was collected using retrospective chart review of patients 
undergoing THA or TKA who were not MRSA positive preoperatively from May 1, 2009 
through September 1, 2011.  IRB approval for the project lasts for one year from the initial date 
of approval until February 14, 2014.    
Resources—personnel, technology, budget, return on investment (ROI).  Quality 
health care is of vital concern to individuals in the United States (U.S.) and to the country’s 
economy.  In 2008, per capita health care costs were $7,681, compared with individual costs of 
$356 in 1970 (Weisfeld, 2011).  During that same year the total cost of U.S. health care was $2.3 
trillion, with payments coming from multiple sources such as private insurance, payment out of 
pocket; and public funding from federal, state and local entitlement programs (Weisfeld, 2011).  
Stone (2010, p. 30) reports: “In fact, healthcare spending is growing at a faster rate than that of 
our economy overall.” 




An important source of health care expenditures is surgical site infection (SSI) following 
total hip arthroplasty (THA) or total knee arthroplasty (TKA).  Courville et al. (2012) 
documented the cost of a total joint revision surgery related to a deep infection as being about 
$100,000; 3-4 times the cost of an initial THA or TKA.  Lentino (2003) reported the cost of a 
THA or TKA SSI at approximately $50,000.   
According to Lee et al. (2010), around 35% of Americans are carriers of Staphylococcus 
aureus.  The authors note colonization rates of Methicillin-resistant Staphylococcus aureus 
(MRSA) of 0.4% to 20.6% have been reported in the literature and that orthopedic surgery 
patients are at risk for MRSA SSIs (Lee et al., 2010).  Decolonization is an existing strategy to 
provide/supply THA and TKA surgery with a decreased risk of MRSA SSIs.     
Kurtz, Lau, Watson, Schmier, and Parvizi (2012) note that in 2010, it was expected that 
approximately 8,136 infections related to hip prostheses and 17,781 infections related to knee 
prostheses would occur.  Projections for 2020, suggest 16,584 infections related to THAs and 
48,971 related to TKAs may develop (Kurtz et al., 2012).  These figures translate into an 
estimated cost to U.S. hospitals of nearly $1.62 billion in 2020 and an estimated cost of nearly $1 
billion by 2014 (Kurtz et al., 2012).  The trend has been that each year individuals, private and 
public health care organizations and insurers face scarcer resources.  In addition, the Patient 
Protection and Affordable Care Act (PPACA) will result in 32 million more Americans having 
health insurance (Knickman, 2011). 
An expectation is that more Americans with health insurance will create an increased 
demand for health services overall, two of which may be THA and TKA surgeries.  This effect 
would demonstrate moral hazard, electing to have a surgery one may not have had in the past 




when uninsured.  If having health insurance is viewed as a type of income increase, the demand 
for surgical services will likely increase as well. 
The goal of this systems change project was to determine the short term success of 
MRSA decolonization beginning on the day of surgery, and to determine whether decolonization 
at the time of surgery was effective in reducing the rate of SSIs for patients having THA or TKA 
surgery at a Midwest hospital as a quality improvement project.  The nares of patients admitted 
for THAs or TKAs at the facility were swabbed to identify the presence of MRSA.  This 
screening was not a new expense as it has been done for all facility patients on admission, 
transfer, discharge and death since 2006.  Patients with newly positive MRSA results and known 
positive patients were decolonized at the time of surgery because they were at increased risk of a 
MRSA SSI by undergoing surgery resulting in a permanent implant.  Mupirocin ointment was 
the drug used for decolonization and intravenous vancomycin was the drug given for 
preoperative antibiotic prophylaxis.  The patients’ nares were also swabbed at discharge, again, 
not a new expense as done for all discharges since 2006.  The results of the swabs were 
compared to determine temporary decolonization.  Surveillance for THA and TKA SSIs was 
done for 90 days postoperatively.   
The market for this project consisted of patients electing to undergo THA or TKA 
surgery at the facility (buyers) and the interdisciplinary group of health care providers involved 
in orthopedic surgery at the facility (sellers).  Decolonization was not “new” technology per se, 
but could be viewed as a supply shifter related to increasing the quality outcomes associated with 
THA/TKA surgery.  More positive outcomes would likely increase the supply of these surgeries.  
Fixed costs associated with this project were the number of patients having THA/TKA 
surgery (which does not change greatly from year to year), utility costs, and software used 




related to the electronic health record.  Some variable costs include medical supplies for lab 
work, drugs and the cost THA/TKA prostheses.  The need to quarantine instrumentation was a 
variable cost.  Vendors may or may not be on a tight schedule providing instrumentation to 
multiple hospitals. 
THA/TKA surgery has associated direct medical costs including imaging and prosthetic 
devices, and direct nonmedical costs such as copays and other out of pocket expenses.  There are 
also intangible costs to the patient such as anxiety, localized pain, deconditioning and decreased 
mobility related to the procedure.  There are indirect costs such as lost work and family time. 
Project costs are listed in Table 5, the cost spreadsheet (Appendix I).  Included are the 
costs of developing the protocol and templates for the project, staff education (such as time for 
employee attendance and for the educator), and initial administrative costs.  There were no 
program material costs, room rental costs, or travel and lodging costs.  Project benefits are 
measured in terms of avoided costs:  admission and discharge labs (Appendix J) are routinely 
collected at the facility; and averted costs:  the estimated cost of a single THA/TKA SSI.  An 
explanation of the ROI calculation, which was favorable, is found in Appendix K.  Generally, if 
the calculated ROI of a project is greater than zero it is considered reasonable to proceed with the 
project.  
  A present value calculation was not discussed with stakeholders during the project 
development process but was examined for this paper.  Appendix L contains a representation of 
present value over a five year time period assuming the medical cost avoided is $50,000, if one 
SSI is prevented.  This would amount to $216,473.83 in savings in present value terms. 
Continuous quality improvement was well served by the implementation of this project.  
Patients colonized with MRSA received a more appropriate prophylactic antibiotic and were 




attempted to be temporarily decolonized during the perioperative and immediate postoperative 
period when the risk of SSI is the greatest.  Decolonization of MRSA positive THA/TKA 
patients not only decreased the risk of SSI for the project patients but decreased the MRSA 
burden in the hospital overall as well with temporary decolonization.   
Preventing infection is about quality of care and patient safety.  It can also be about costs 
avoided/averted, loss reduction (e.g., decreased length of stay) and even profit.  Decisions are 
made about projects such as this one and strategies are implemented.  Outcome evaluation data 
determines whether expectations are met.  This cost benefit analysis is an attempt at making a 
business as well as a clinical case for preventing SSIs through the use of screening and 
decolonization.  
Support from site.  The facility had the resources to support the decolonization project.  
However, although the hospital epidemiologist, the chief of surgery, and the chief of orthopedics 
were in favor of the project, a limitation was that the residents rotate approximately every two 
months which impacted continuity of the project.  The chief of orthopedics and the orthopedic 
nurse coordinator included education about this protocol during the resident orientation and 
emphasized the importance of adherence to the protocol.  The protocol itself was added to the 
orthopedic resident handbook.  This action added to the project’s feasibility.  The scalability of 
the project involved the orthopedic team, one nursing unit pre and postoperatively and the 
operating room staff assigned to THA/TKA surgeries.   
This project was considered a pilot study.  It has been continued beyond the pilot phase 
as there is an increasing body of evidenced-based literature to support preoperative MRSA 
decolonization (van Rijen et al., 2008; Lonneke et al., 2010; Courville et al., 2012; Lee et al., 




2010).  Costs should not expand greatly beyond increases for drugs and lab related to those 
described in Appendices I, J, and K.   
Ethical considerations.  Universal screening was implemented to determine the MRSA 
status of patients.  In order to meet a standard informed consent, patients were allowed to make 
the choice about whether or not to consent to a treatment or procedure.  This applied to MRSA 
screening on admission.  The universal screening strategy was implemented under an existing 
directive, which ensured the risks and benefits of the screening procedure were discussed with 
every patient on admission.  This discussion included how the results of the swabs were used, 
and how the results when positive affect patient care, for example, contact precautions were 
implemented.  The MRSA screening program promoted the principle of the greatest good for the 
greatest number of people as one part of a bundled approach to decrease the MRSA burden 
facility-wide and thus decrease the risk of transmission for patients who were not MRSA 
colonized.  Careful consideration of these measures established safe, quality patient care within 
the practice of active MRSA surveillance. 
Conclusion.  Many of the human and financial assets required for this project were 
already in place at the facility.  Positive outcomes from this project should conserve existing 
resources. Reductions in length of stay may occur, related to a decrease in SSIs.  The overall 
facility burden of MRSA should decrease.  Mortality may decline as well.  Successful 
decolonization has the potential to result in improved patient-centered quality care and a 
favorable return on investment.    
 




  Chapter 4 
Data Analysis.   
During the study period 299 patients underwent THA or TKA procedures.  Ten (3.5%) of  
299 patients were positive on admission for MRSA.  Four historical controls were selected for 
each case for a total of 40 controls.  Controls were matched by age, gender, type of surgery, and 
location of surgery.  Only one control was MRSA positive on admission.  
Project Evaluation:  Evidence-based Methodology and Analysis.  Comparisons were 
made between the 10 cases who underwent decolonization for MRSA and 40 control subjects 
who did not.  By definition all 10 of the cases were positive for MRSA prior to surgery.  One of 
the control subjects was positive for MRSA on admission. The remaining 39 controls were not.  
All subjects were male and were operated on during the day of admission.  None had acute renal 
failure, were on dialysis, or had chronic obstructive pulmonary disease (COPD).  The mean age 
was 62.9 and mean body mass index (BMI) was 31.9 (Appendix M). 
 Chi-squared tests were used to compare the two groups on surgery type, surgery side, 
duration of surgery, ASA score, length of pre-operative stay, type of pre and post-operative 
antibiotic used, use of mupirocin, diabetic condition, tobacco use, preoperative albumin level, 
use of tranexamic acid, history of MRSA infection/colonization, MRSA colonization at 
discharge, SSI identified at ≤ 30 days from surgery, and at ≤ 90 days from surgery (Appendix N). 
 Findings (Appendix O) showed that case patients were significantly more likely than the 
control patients to have a history of MRSA colonization/infection prior to admission for surgery 
(Fisher’s Exact=.001), and no MRSA colonization at discharge (Fisher’s Exact=.022).  There 
was a significant difference in pre-operative antibiotic use, with 85% of control patients 
receiving cefazolin and 70% of case patients receiving vancomycin (Χ²(2)=32.8, p<.001).  Use 




of mupirocin was also significantly higher in case subjects at 70% compared with no use in 
control patients (Χ²(1)=32.6.p<.001).  Only case patients received tranexamic acid (40%), while 
none of the control subjects did (Fisher’s Exact=.001).  Finally, 80% of the control subjects were 
receiving no treatment for diabetes where 80% of cases were receiving either dietary or 
medicinal treatment for diabetes (Χ²(3)=15.0, p<.002).  No other significant differences were 
observed.  Analyses of variance found no difference in age or BMI across the groups.  
 MRSA colonization in the cases was reduced from 100% to 30% pre to post surgery 
(Wilcoxon Signed Ranks Z=2.65, p=.008).  The impact of tranexamic acid on postoperative 
colonization was also examined.  No significant difference was found with use of tranexamic 
acid among those colonized postoperatively and those not colonized.  Observation of site 
infection at 30 and 90 days postoperatively found only two patients, both controls, with a SSI.  
One SSI was revealed at postoperative day 10 and one at postoperative day 82.  Different 
pathogens were identified.   
 Conclusion.  Of the 11 patients with pre-operative MRSA colonization various predictors 
of postoperative infection were examined.  However, the small sample size precluded 
meaningful inferential statistical tests related to these variables.  Descriptively, two of the three 
patients with MRSA colonization on discharge had knee surgery lasting over two hours.  Two of 
the three patients remaining colonized on discharge also received cefazolin rather than 
vancomycin postoperatively.  Only one of the three patients remaining colonized on discharge 
received mupirocin.  Two of the three colonized on discharge received tranexamic acid in the 
perioperative period. 
  





Discussion of Findings and Outcomes 
 Nasal colonization of MRSA may increase the risk of SSI in patients undergoing total 
joint replacement surgery such as THA or TKA.  A growing body of literature exists related to 
the topic of MRSA and SSI as a complication of Orthopedic surgery (Kim et al., 2010; Gupta et 
al., 2011; Yano et al., 2009; Hadley et al., 2010; Buelmann et al., 2008).  There is evidence in the 
literature supporting preoperative decolonization for patients planning to undergo surgery with a 
permanent implant.   
While there is evidence favoring preoperative decolonization, no standard protocol exists.  
Much of the literature describes beginning the decolonization process at five days before surgery.  
This project sought to determine whether patients scheduled to undergo THA or TKA surgery 
could be temporarily decolonized by implementing a protocol beginning on the day of surgery.  
The project also examined whether patients were identified with a SSI within the postoperative 
period as defined by the NHSN.  Demographic data, procedure-related data, and other risk factor 
data potentially associated with SSIs were also examined.   
Some difference between the cases and controls varied widely when considering 
particular variables.  While 50% (5/10) of the cases had a history of MRSA 
infection/colonization prior to admission for surgery, none of the controls (0/40) did.  Because 
historical controls were used, only eligible case patients received tranexamic acid in the 
perioperative period.  Eighty percent of the cases were found to use dietary restrictions, oral 
medications, or insulin injections to control diabetes; while 80% of the controls did not as they 
did not have a diagnosis of diabetes.  No SSIs were identified from 0 to 90 days in the cases.  
Two SSIs were identified from 0 to 90 days in the control group.   




There was no difference in mean age (62.9 years) between the cases and controls as 
matching age within three years was one of the selection criteria for controls.  BMI data was very 
similar for both groups with the mean BMI for the cases at 33.19 kg/m², and at 31.67 kg/m² for 
the controls. There were no odds ratios to examine because the small number of observations 
prohibited a regression analysis.  An additional factor of interest that was not significant, yet 
emerged from the analysis was that 100% (10) of the cases had an ASA score of 3, while only 
two-thirds of the controls 67.5% (27) of the controls were assigned an ASA score of 3.  
The findings of this pilot project suggest that beginning decolonization on the day of 
surgery may be a reasonable approach given that 7 of the 10 cases had negative MRSA swabs at 
discharge.  Project results also demonstrate the need for further research about the benefits of 
MRSA decolonization related to THA and TKA surgery and preventing SSI.  In addition, the 
findings lend support to the preliminary work and outcomes of other researchers such as 
Buehlmann et al. (2008), who found that MRSA decolonization was successful when individuals 
completed the full treatment course.  It may be that beginning decolonization on the day of 
surgery and continuing the process while the patient is hospitalized creates a supportive 
environment that assists the patient in obtaining a positive outcome.   
The results of this project are also consistent with those of Kim et al. (2010), who found 
that it is feasible to implement a facility-wide prescreening program to identify and eliminate 
MRSA colonization in patients undergoing orthopedic surgery.  In addition the authors found a 
significant decrease in SSIs.  That finding was not demonstrated with this SCP as the limited 
number of subjects prohibited such a statistical analysis. 
Methodological issues must be addressed to guide similar projects about decolonization 
in the future.  Since the convenience sample was limited to only one Midwestern teaching 




hospital, the findings are not generalizable to patients in all hospital settings.  A possible solution 
would be for multiple hospitals from different regions to participate in a similar study to assist in 
overcoming this limitation.  Access to a larger sample size would also make a significant 
contribution towards obtaining meaningful results. 
  Another factor to consider when developing a future proposal would be to include a 
screening swab at a three or four month postoperative appointment to determine the 
sustainability of the temporary decolonization.  This knowledge is of importance to Infection 
Preventionists as NHSN SSI surveillance for THA and TKA procedures now extends for 90 days 
rather than the previous one year following a procedure (CDC, 2013).  With large enough sample 
sizes it may be possible in the future to examine whether there is an association between 
decolonization and prevention of MRSA SSIs. 
While no effect was demonstrated statistically related to this project, the concurrent study 
with the same patient population must be addressed as an unforeseen confounding factor.  
Communication among investigators about other active or proposed studies is critical in avoiding 
the addition of such a confounding factor.  Close inter-relationships may result in both variables 
appearing weaker and unnecessarily compromising results.  
Conclusions 
 Patient safety and satisfaction, evidence-based quality care outcomes, costs of an SSI, 
and making good use of scarce resources were the driving forces for change with this project.  
The system change of decolonizing THA and TKA patients on the day of surgery appears to 
have been successful although the number of cases was small.  A multidisciplinary group led by 
nursing was required to establish, implement, and support the change.  The protocol continues to 
be used and was included in the handbook that is distributed to orthopedic residents at the 




facility.  Despite the limitations encountered with this project, the results may be useful in 
stimulating other hypotheses for future research.    
Recommendations 
 DNP as a consultant.  A doctoral prepared nurse has the ability to define and propose 
changes to administrators within the organization.  This recommendation should enhance the 
consultation role within organizations in various clinical areas, with a critical eye toward 
scrutinizing standards of care.  One example is forming and leading multidisciplinary teams to 
revise protocols and policies such as the MRSA decolonization project for patients undergoing 
THA and TKA procedures.  The evidence-based change in practice of MRSA decolonization 
better serves the patient, potentially leads to both a quality and cost beneficial health care 
outcome by reducing the MRSA burden in the facility and possibly preventing SSIs.  Activities 
such as this not only demonstrate the DNP’s skill at collaboration, but create an opportunity to 
advance the field of nursing by sharing and gaining new knowledge from colleagues in other 
disciplines. 
 It is also recommended that DNPs in a consultative role continue to not only maintain, 
but augment skills related to information technology and virtual environments.  These essential 
skills for searching and reviewing literature, mining data, performing statistical analyses, 
performing evaluations, providing health education, and for communication in general call for 
lifelong learning.  Utilizing health informatics increases opportunities for telemedicine contact 
with patients and web-based conferencing, education, and mentoring opportunities for nurses as 
well. 
 A final recommendation for DNP nurses in a consultative role is to remain aware of 
politics, policy making, and of the importance of forming partnerships when planning a systems 




change.  Depending on one’s practice location communications may need to involve additional 
key stakeholders as partners in the planning to ensure that implementation proceeds effortlessly 
and efficiently.  For example, providing a proposal to labor representatives for review and 
comment prior to overall group planning sessions may alleviate unnecessary future controversy.  
Labor representatives can provide another voice for frontline staff during future discussions 
involving the proposed change, and members may be inclined to speak more directly about 
concerns with their representative. 
 Potential transferability of project findings.  The findings from the project itself are 
transferable to some extent.  Three initial issues should be considered.  First it is important to 
consider this as a pilot project because the anticipated number of cases was not observed, 
resulting in a limited number of cases.  Second, the facility interested in a similar study should 
know the prevalence of MRSA in the institution prior to beginning an investigation.  This would 
assist the researcher to a more accurate estimate of the number of expected cases and in 
determining the number of historical controls to choose.  Third, this was a convenience sample, 
not a randomized one.  Randomization may create difficulty obtaining sufficient numbers of 
cases and controls depending on the criteria identified for matching.  This would also increase 
the length of time that the study would be implemented.    
Assuming further interest in a similar project, the first requirement would be that the 
facility had the capability to perform PCR analysis of the nares swabs.  Without the forty-five 
minute to one hour turnaround time PCR analysis offers it would not be possible to begin 
decolonization at the time of the surgical procedure.  Cultures require twenty-four to forty-eight 
hours for results of swabs collected from patients arriving on the day of surgery.  A similar 
project would not be possible in a facility without MRSA PCR analysis capabilities. 




 If a facility has the ability to perform PCR analysis of the nares swabs it would be 
prudent to align with other sites to implement a multisite project in order to increase the sample 
size overall which would improve the likelihood of identifying more cases.  This would 
contribute to the generalizability of the study results.  Greater numbers would also permit a 
regression analysis and would result in odds ratios that could be examined.  Finally, the timeline 
for the study should be extended to greater than the one year implemented for this pilot project.  
This would assist in determining an association between decolonization and a decrease in SSI 
rates. 
The skills required by the nurse investigator for this project are transferable to other 
system change projects.  Knowledge of evidence-based practice, nursing and change theory, 
organizational culture, negotiation skills, and multidisciplinary collaboration all have far-
reaching application. 
Dissemination plan.   The initial dissemination of the project results will be in a public 
presentation at the university where the investigator is enrolled in the DNP program.  There are 
numerous other potential options for disseminating the results.  One is to present the findings at 
the project site’s nursing grand rounds.  This will be in addition to presenting at staff meetings 
for the operating room nurses, CRNAs, microbiology lab, pharmacy, and to nurses on the 
surgical unit.  The results will also be presented at the operating room committee and at the 
onsite orthopedic surgery subspecialty meeting.  In addition, there are two poster presentation 
opportunities in the site facility.  One is during research week and the other during nurse’s week.  
The onsite nurse newsletter has requested an article about the project. 
 Externally, a submission for a poster presentation to peers in infection prevention and 
control at the annual state APIC conference will be completed.  A regional group of nurses who 




collect surgical quality improvement data have requested a web-conference presentation.  It is 
possible to present to a similar regional group of infection preventionists.  Finally, the possibility 
exists to submit an article to a nursing journal. 
 The project as a foundation for future scholarship.  This project provides a foundation 
for future nursing scholarship.  It may directly impact scholarship relative to MRSA 
decolonization if the investigator expands the pilot project. Indirectly, the project affects 
scholarship because the skills demonstrated by the nurse investigator are generic to any project 
where evidence-based practice is applied to improve quality health outcomes, and the results of 
the applied research are disseminated to address issues in clinical practice.  Doctoral prepared 
nurses are willing and ready to examine and revise existing nursing practice to produce improved 
outcomes and patient satisfaction.  They are nurse leaders who have designed and implemented a 
project beginning with developing the research question to disseminating the practice innovation.  
Confidence is gained or increased by completing such a project.  This is empowering, which is 
valuable because it can be challenging to change clinical practice. 
 American colleges of nursing essentials.  A DNP project must be scholarly.  It should 
be developed with the intent of translating research findings into practice.  This project 
implemented a change in the standard of care in the clinical setting of total hip and total knee 
joint replacement surgery as a strategy to temporarily decolonize patients beginning on the day 
of surgery, and potentially prevent SSIs in this patient population. 
 The project was in keeping with the American Association of Colleges of Nursing 
(AACN) Essentials of Doctoral Education for Advanced Nursing Practice (2006).  Related to 
Essential I, Scientific Underpinnings for Practice, the nurse investigator formed a 
multidisciplinary group to plan and implement the project that included:  pharmacy, the 




orthopedic nurse coordinator, CRNAs, the clinical microbiology laboratory, two nurse managers, 
the chief of orthopedic surgery, and the hospital epidemiologist.  Concepts and principles from 
all disciplines were discussed and integrated into the protocol.  The group determined 
decolonization to be a significant strategy to enhance health care delivery.  Implementing 
decolonization was a new practice approach for the facility. 
 Essential II, Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking (2006), was also addressed by the project.  Business principles were applied in 
discussion with pharmacy and informatics staff.  The investigator negotiated with pharmacy 
concerning the use of a small unit dose tube of ointment by the CRNAs in the operating room, 
and the use of a multi-dose tube of ointment for use on the surgical unit and for patient use 
during the two days following discharge.  When considering cost benefit, the use of unit dose 
tubes were more efficient and less wasteful for the CRNAs in the operating room who were 
administering the initial dose of ointment.  When this was determined informatics staff became 
involved to build the pre and postoperative order sets.   
The above is an example of a small portion of this pilot project, which following 
implementation offered support for the hypothesis that beginning decolonization on the day of 
surgery in a supportive environment can result in temporary decolonization.  This may improve 
post-operative health outcomes, and avoid the expenses that may be incurred with an extended 
hospitalization associated with a SSI. 
 The project was also in keeping with Essential III, Clinical Scholarship and Analytical 
Methods for Evidence-Based Practice (2006).  Gaps in practice were identified with review of 
the first patients who participated in the decolonization protocol.  The outcomes were evaluated 
at the facility locally, but indirectly had implications for practice at the regional level as the 




facility was and is a referral site for THA and TKA surgeries.  Practice guidelines were 
formalized again and resident staff re-educated.  The protocol was then included in the handbook 
provided to all residents in the Orthopedic Surgery Subspecialty. 
 Essential IV, Information Systems/Technology and Patient Care Technology for the 
Improvement of Health Care (2006), was addressed as well during the project.  Order sets for the 
protocol were developed by the nurse investigator and a clinical applications coordinator.  Data 
was abstracted from the electronic medical record and entered into a spreadsheet for analysis.  
Knowledge gained from continuous review of the overall process was summarized and added to 
the protocol entered into the handbook described above. 
 Implementing the project further developed knowledge and skills for the nurse 
investigator related to Essential V, Health Care Policy for Advocacy in Health Care (2006).  An 
issue, no existing standard of care for decolonization of patients undergoing THA or TKA 
surgery, was identified and action was taken to change practice.  The process required a multi-
disciplinary approach and consensus building.  As stated earlier, the protocol is unique to the 
facility where the project was implemented, but influences a regional patient population through 
referrals made by other facilities for THA and TKA surgery. 
 Essential VI, Inter-professional Collaboration for Improving Patient and Population 
Health Outcomes (2006), suggests that the DNP use communication and collaboration skills to 
develop and implement practice guidelines.  The nurse investigator was the leader in planning 
and implementing the pilot project.  Partners from other disciplines were invaluable in 
developing a project that offers support for a decolonization protocol beginning on the day of 
surgery. 




 The decolonization pilot project met Essential VII, Clinical Prevention and Population 
Health for Improving the Nation’s Health (2006).  Project findings suggest that this is a clinical 
prevention strategy that may result in temporary decolonization in the perioperative period, 
which may contribute to decreased morbidity by reducing the number of SSIs.  Patients receiving 
total hip or total knee implants were the population served.  Healthy People 2010 included 
Developmental Objective 2-6:  Eliminate racial disparities in the rate of total knee replacements.  
This project did not directly address racial disparities and joint replacement, but was in keeping 
with a history of studying orthopedic implants related to a population-based health outcome. 
 Finally, regarding Essential VIII, Advanced Nursing Practice (2006), the nurse 
investigator leading the project met these components as the project evolved.  The nurse 
designed, implemented and evaluated the decolonization pilot.  Although therapeutic 
relationships were not established with the patient population, professional relationships with 
other disciplines were enhanced by developing a new intervention and changing practice.  This 
project demonstrates leadership and independence in nursing practice, in advancing 
interdisciplinary partnerships, and in influencing patient health outcomes through a systems 
change.      
 Closing.  This project has implications for DNPs and other health professionals who are 
involved in providing care during the perioperative period for patients undergoing THA and 
TKA surgery.  Methicillin-Resistant Staphylococcus aureus prevalence will vary by facility, and 
thus the risk of colonization, transmission, and potential for SSI.  Continued attention must be 
directed toward developing evidence-based protocols that will reduce the above risks and result 
in quality health care outcomes along with patient satisfaction.  Adherence to protocol as in the 
case of this project will rely not only on the health professionals, but also on the patients.  This 




pilot project suggests that identifying existing nasal MRSA and beginning decolonization on the 
day of surgery for patients undergoing THA or TKA surgery may effectively result in temporary 
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Appendix A:  Nola J. Pender (1996) Health Promotion Model Diagram, www.http://hdl.handle.net/2027.42/85351 [used with permission] 
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SSI rate during study 
period lower than in 
control period (59% 
reduction rate, 
p=0.009), Higher SSI 
rate in MRSA carriers 
compared with non- 
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op outcomes   
Positive pre-op MRSA 
culture significant for 
positive post-op culture 
(p<0.001), MRSA SSI 
(p=0.01), and other 
post-op infection 
(p<0.01) unadjusted.   
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86/284 colonized, 81 
with methicillin 
sensitive S. aureus and 
5 with MRSA, number 
of MRSA carriers did 
not increase from 2003-
2005; no correlation 
between MRSA 
carriage, demographic 
data, SSI, or surgical 
procedure 
 




































































completed in 87% 
(54/62) with a mean of 
2.1, SD + 1.8.  MRSA 
sites: nose 68% 
(42/62), throat 53% 
33/62, perianal 53% 
33/62, rectal 58% 
(36/62), inguinal 49% 
(30/62).  65% required 
oral antibiotic 
treatment to decolonize 
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and CHG resistance 
OR=3.4, 95% CI (1.5-
7.8), p=0.004; age/1yr 
increment OR=1.04, 
95% CI (1.02-1.1), 
p=0.001; hospital 
within 2 yrs OR=2.4, 
95% CI (1.1-5.7), 
p=0.04; wound/ulcer 
OR=5.7, 95%CI (1.8-
17.6), p=0.003; MRSA 
inactive antibiotic use 
OR=3.1, 95% CI (1.3-
7.2), p=0.01; central 











Appendix C:  Table Ranking the Evidence for Clinical Practice Guidelines and Systematic Reviews (Table 2)  
Study Author Purpose Population Results  Practice 
Applicability 
Risk/Benefit  Level/Quality 
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 APPENDIX D:  AGREE II Online Appraisal Tool 
A critical appraisal of:  
Clinical Practice Guidelines by the Infectious Diseases Society of America for the 
Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and 
Children 
using the AGREE II Instrument  
Created with the AGREE II Online Guideline Appraisal Tool.  
No endorsement of the content of this document by the AGREE Research Trust should be 
implied.  
Appraiser: Laurel Chelstrom 
Date: 12 May 2012 
Email: ljchelstrom@stkate.edu 
URL of this appraisal: http://www.agreetrust.org/view-appraisal/?doc=2294 
 
Overall Assessment 
Title: Clinical Practice Guidelines by the Infectious Diseases Society of America for the 
Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children 
Citation:  
Overall quality of this guideline: 6/7 
Guideline recommended for use? Yes 
 
 






Guideline sections begin with a question followed by quantified recommendations with a 
summary of recent evidence supporting the recommendation. There is a research gaps section 
which discusses areas of limited/conflicting data or the need for additional research.  
Domain Total 
1 - Scope and Purpose 21 
2 - Stakeholder Involvement 11 
3 - Rigour of Development 46 
4 - Clarity of Presentation 21 
5 - Applicability 19 
6 - Editorial Independence 14 
1. Scope and Purpose 
1. The overall objective(s) of the guideline is (are) specifically described. 
Rating: 7 Strongly Agree 
Yes, in the brief executive summary. 
2. The health question(s) covered by the guideline is (are) specifically described. 
Rating: 7 Strongly Agree 
Yes, expressed in question form and specific responses for adult or pediatric patients.  
3. The population (patients, public, etc.) to whom the guideline is meant to apply is 
specifically described. 
Rating: 7 Strongly Agree 
Yes, adults and children with MRSA infections. 
 
2. Stakeholder Involvement 
4. The guideline development group includes individuals from all relevant professional 
groups. 
Rating: 2 




Reviewer was unable to determine. Organizations are specified for the individuals, not their titles 
or roles. All authors/panelists are considered infectious disease experts in management of 
MRSA. 
5. The views and preferences of the target population (patients, public, etc.) have been 
sought. 
Rating: 2 
External peer review feedback of the draft is reported in the document.  No report of comments 
from patients or the public concerning the development of the document.  
6. The target users of the guideline are clearly defined. 
Rating: 7 Strongly Agree 
Yes, practitioners and patients. 
 
3. Rigour of Development 
7. Systematic methods were used to search for evidence. 
Rating: 3 
The search identified PubMed as the database.  A limit was English-language only.  Years 
searched were from 1961-2010.  Search terms used were “methicillin-resistant Staphylococcus 
aureus” or “MRSA.”  The focus was on human studies however some experimental animal 
studies, in vitro data, and abstracts from national meetings were included. The authors reported 
many recommendations were developed from observational studies or small case series studies 
combined with the opinion of expert panel members.  
8. The criteria for selecting the evidence are clearly described. 
Rating: 7 Strongly Agree 
Yes, an A (good evidence to support a recommendation for or against use), B Moderate evidence 
to support a recommendation for or against use), C (Poor evidence to support a recommendation) 
scale was used to rate the strength of recommendations.   
A scale for quality of evidence was scored as:  I (evidence from ≥ 1 properly randomized 
controlled trial); II (evidence from ≥ 1 well designed clinical trial, without randomization from 
cohort or case-controlled analytic studies, preferably from > 1center; from multiple time-series, 
or from dramatic results from uncontrolled experiments); and III (evidence from opinions of 




respected authorities based on clinical experience, descriptive studies or reports of expert 
committees). 
9. The strengths and limitations of the body of evidence are clearly described. 
Rating: 7 Strongly Agree 
Yes, detailed narrative descriptions are included for each question. 
10. The methods for formulating the recommendations are clearly described. 
Rating: 7 Strongly Agree 
Yes, use of teleconference and annual meetings of all members. All members participated in 
preparation and review of the draft guideline. Feedback from external peer reviewers was 
obtained. Guideline was endorsed by Pediatric Infectious Diseases Society, American College of 
Emergency Physicians, and American Academy of Pediatrics. The guideline was reviewed and 
approved by IDSA Standards and Practice Guidelines Committee and the IDSA Board of 
Directors.  
11. The health benefits, side effects, and risks have been considered in formulating the 
recommendations. 
Rating: 7 Strongly Agree 
Discussions and recommendations are detailed and decisions are clear and succinct. 
12. There is an explicit link between the recommendations and the supporting evidence. 
Rating: 7 Strongly Agree 
Yes, evidence-based literature is referenced throughout the document. 
13. The guideline has been externally reviewed by experts prior to its publication. 
Rating: 7 Strongly Agree 
Yes, reviewer commented on this earlier in #10 under Rigour of Development. 
14. A procedure for updating the guideline is provided. 
Rating: 1 Strongly Disagree 
Reviewer did not see a procedure in place for this. 
 




4. Clarity of Presentation 
15. The recommendations are specific and unambiguous. 
Rating: 7 Strongly Agree 
The recommendations are clearly detailed and followed with an evidence summary. 
16. The different options for management of the condition or health issue are clearly 
presented. 
Rating: 7 Strongly Agree 
Yes, alternatives are presented (see decolonization for example) and are stratified by adult and 
child. 
17. Key recommendations are easily identifiable. 
Rating: 7 Strongly Agree 
Yes, some key recommendations are identified in the executive summary and some are identified 
as performance measures on the concluding page of the document. 
 
5. Applicability 
18. The guideline describes facilitators and barriers to its application. 
Rating: 4  
Not clearly labeled as facilitators or barriers, or stated in a particular section.  Caution and 
controversy are noted appropriately.    
19. The guideline provides advice and/or tools on how the recommendations can be put into 
practice. 
Rating: 7 Strongly Agree 
Yes, throughout the document. 
20. The potential resource implications of applying the recommendations have been 
considered. 
Rating: 7 Strongly Agree 




Yes, for example personal and environmental hygiene and wound care in the home are discussed. 
21. The guideline presents monitoring and/or auditing criteria. 
Rating: 1 Strongly Disagree 
Implied in some areas but not defined. 
 
6. Editorial Independence 
22. The views of the funding body have not influenced the content of the guideline. 
Rating: 7 Strongly Agree 
All panel members complied with IDSA policy including actual, potential or apparent conflict of 
interest.  Panel members were asked to identify links to companies developing products that may 
be influenced by dissemination of the guideline.  Information was requested regarding 
employment, consulting, stock ownership, honoraria, research funding, expert testimony, or 
participation on company advisory committees. 
23. Competing interests of guideline development group members have been recorded and 
addressed. 
Rating: 7 Strongly Agree 
Potential conflicts of interest were listed in the Acknowledgement section. 
 












Appendix E:  Table Ranking the Evidence for Systematic Reviews (Table 3)  
Study Author Purpose Population Results  Practice 
Applicability 
Risk/Benefit  Level/Quality 
McGinigle, 2008 Use of active 
surveillance 
cultures (ASC) 
to reduce MRSA 
Patients in 
MICU or SICU 
Existing 
evidence favors 
use of ASCs, as 
evidence is poor 
recommendations 
can’t be made 
ASC required by 
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itself was good 
although 
negative as 
studies of poor 
quality. 
van Reijen, 2011 Determine if 
nasal mupirocin 










Use of mupirocin 
in nasal S. aureus 
carriers is 
associated with a 
decrease in S. 
aureus infections 
Clinical setting 
similar to those 
in guideline 
Benefit: 





















Appendix F:  Ranking the Evidence (Table 4) 
Literature Level Ranking Quality Ranking 
   
APIC, 2010 (MRSA guideline) Level 5 Good 
APIC, 2010 (Orthopedic guideline) Level 5 Good 
Liu, C, et al, 2011 (IDSA guideline) Level 3 Good 
McGinigle, K, 2008 (systematic review) Level 5 Poor 
van Rijen, M, 2011 (systematic review) Level 1 Good 
Gupta, K. et al, 2011 (original article) Level 4 (retrospective cohort) Good 
Kim, D. et al, 2010 (original article) Level 4 (prospective cohort) Good 
Yano, K. et al, 2009 (original article) Level 4 (prospective cohort) Good 
 
Rating System for the Hierarchy of Evidence for Intervention/Treatment Questions: 
 
Level 1:  Systematic review or meta-analysis of all relevant randomized controlled trials (RCTs), or evidence-based clinical practice 
    guidelines based on systematic reviews of RCTs 
Level 2:  Evidence from at least one well-designed RCT 
Level 3:  Evidence from a well-designed controlled trial without randomization 
Level 4:  Evidence from well-designed case-control and cohort studies 
Level 5:  Evidence from systematic reviews of descriptive and qualitative studies 
Level 6:  Evidence from a single descriptive or qualitative study 
Level 7:  Evidence from the opinion of authorities  and/or reports of expert committees   
 
(Melnyk, & Fineout-Overholt, 2011, p. 12).  Modified from Guyatt, G., & Rennie, D. (2002). Users’ guides to the medical literature.     
     Chicago, IL: American Medical Association; Harris, R. P., Hefland, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., 
     Teutsch, S. M., et al. (2001). Current methods of the U. S. Preventive Services Task Force: A review of the process. 
     American Journal of Preventive Medicine, 20, 21-35. 
 
Quality Criteria:  
 
Good:   Evidence includes consistent results from well-designed, well-conducted studies in populations that directly assess effects on 
health outcomes.  (Quality Criteria continue on the next page) 




Fair:      Evidence is sufficient to determine the effects on health outcomes, but the strength of the evidence is limited by the number, 
quality, or consistency of the individual studies, generalizability to routine practice, or indirect nature of the evidence on 
health outcomes. 
 
Poor:    Evidence is insufficient to assess the effects on health outcomes because of limited number or power of studies, important 
flaws in their design or conduct, gaps in the chain of evidence, or lack of information on important health outcomes. 
 
U. S. Preventive Services Task Force (USPSTF) [May 2008] grades the quality of the overall evidence for a service on a 3-point 
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 Get MRSA nares swab 
order from CPRS 
Go to clean storage 
room  
Get culturette and 
biohazard bag  
 Go to desk 
Get lab request slip 
and label  
Complete lab slip 
and label  
Perform hand 
hygiene  
Go to cart  
Get gown and 
disposable gloves  
Don gown and gloves  Verify patient 
(check armband) 
fo forID  




Swab collection ended, 
document in CPRS 
Open package, 
remove swab  
Insert swab 1” into 
nostril, roll x3 
Same swab, repeat other 
nostril 
Return swab to tube 
Label tube, place in 
biohazard bag 
Remove gown and 
gloves 
Gown to hamper 
Gloves to trash 








Appendix H:  Anesthesia workflow diagram for decolonization of MRSA positive THA and TKA patients 
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      Yes   
• Known MRSA positive patients are 
flagged in CPRS postings. 
• Check with Orthopedics about 
orders for vancomycin and 
mupirocin for newly MRSA 
positive patients 
• Orthopedics is responsible for 
writing orders for known MRSA 
positive patients 
Instructions for opening and applying 
Bactroban nasal (Mupirocin calcium 
ointment 2%) from the 1 X 1.0 gram 



















Appendix I:  Table 5, Cost Spreadsheet Based on 30 THA and TKA Surgeries/Month 
 
(Costs highlighted in yellow are annual repeating costs based on a 10% facility prevalence of 
MRSA, assuming 3 THA or TKA patients/month will be either newly or known MRSA positive) 
Supplies/other 
variable 
New Cost Avoided Cost Averted Cost 
1 THA/TKA SSI   ‡$50,000.00  
2 Admit PCR assay  $51.00(3)(12)=$1836.00  
3 Discharge Agar 
plate 
 $14.00(3)(12)=$504.00  





5 Ancef x 24 hours $3.00(3)(12)=$108.00   
6 Mupirocin unit 
dose 
$5.00(3)(12)=$180.00   
7 Mupirocin 
multidose 
$5.00(3)(12)=$180.00   
8 Staff education by 
IP* 
   
8a 2nd floor RNs** 
by IP 
$100.00 (4x30”) IP 
RN 
$800.00 (rounds x 4) 
for 8 nurses 
  
8b CRNAs*** by IP $25.00 (1x30”) IP RN 
$800.00 (staff mtg x1) 
for 32 CRNAs 
  
8c  Lab staff† by IP $13.00 (1x15”) IP RN 
$200.00 (staff mtg x1) 
for 12 lab personnel 
  
8d  Pharmacy†† by 
IP 




9  Mtgs w/Ortho 
Chief & IP††† 





10 Mtgs w/Ortho RN 
& IP 
(Administration) 






template, CAC• & IP  









13 Totals: $3933.00 $2340.00 $50,000.00 




All salaries below are hypothetical.  All amounts above were rounded for ease of calculation. 
Drug costs were estimated by Pharmacy.  Pharmacy tech time is included, thus true drug cost to 
VA may vary from above amounts if actual tech grade and step data is considered.      
*Infection Prevention RN salary=$50.00/hour 
**2nd floor RN salary=$50.00/hour 
***CRNA salary=$50.00/hour Orthopedics Chief salary=$125.00/hour 
†Lab personnel salary=$16.00/hour 
††Pharmacy assistant chief salary=$50.00/hour 
†††Chief of Orthopedics salary=$125.00/hour 
•Computer applications coordinator (CAC) salary=$50.00/hour 
‡2003 article quoted cost of a THA/TKA SSI as approximately $50,000.00.  This amount  








































Appendix J:  Lab Costs for MRSA Nasal Swab Surveillance 
 
 
PCR assay costs (admission*): 
 
Tech accessioning time=2 minutes=$3.60 
PCR consumables=$35.14 
Setup time=3 minutes=$5.40 
Tech time to read and report out=2 minutes=$3.60 
 
Materials needed to process: 
1 ten part label=$0.01 
2 staples=$0.01 
1 card stock (workcard)=$0.02 
1 pair nitrile gloves per specimen=$1.75 
1 COPAN swab=$0.80 
Bleach and alcohol to countertop after setup per specimen=$0.10 
 




Agar plating costs (discharge): 
Tech accessioning time=2 minutes=$3.60 
Agar plate cost=$2.33 
Plating time=1 minute=$1.80 
Tech time to read and report out=2 minutes=$3.60 
 
Materials needed to process: 
1 ten part label=$0.01 2 staples=$0.01 
1 card stock (workcard)=$0.02 
1 pair nitrile gloves per specimen=$1.75 
1 COPAN swab=$0.80 
 




*Admission lab is more costly to process as results are available in 45 minutes to 1 hour, so 
patients can be placed in isolation precautions more quickly.  The discharge swab is plated and 
less expensive because results are not available for 24-48 hours.  Isolation precautions are no 









Appendix K:  Cost Benefit Summary Calculations 
 
Total decolonization costs for initial year:  $3933.00 
 
Total averted cost if one THA/TKA SSI is averted:  $50,000.00 
 
Total avoided annual cost for admission and discharge labs:  $2340.00 
 
Total benefits:  $52,340.00 
 
 
Benefit Cost Ratio = Total benefits/Total costs = $52,340/$3933 = 13.3 
 
 
Return on investment (ROI) = Total benefits – Total costs/Total costs x 100 = 
  
 ($52,340 - $3933)/$3933 x 100 = 
 ($48,407/$3933) x 100 = 1230 = ROI 
 
ROI figure is greater than zero it is worthwhile to consider investing in this project.  A limitation 
is possible development of Mupirocin resistance.  Decolonization should be limited to high risk 





























Appendix L:  Present Value Calculation 
 
 
Assume medical cost avoided for 1 THA/TKA SSI = $50,000 
Assume 5% interest 
 
 
Present Value of 5 years avoided medical cost of 1 SSI assuming a 5% interest rate: 
 
PV savings in year 1:  $50,000/$1.05=$47,619.05 
PV savings in year 2:  $50,000/(1.05)²=$45,351.47 
PV savings in year 3:  $50,000/(1.05)³=$43,191.88 
PV savings in year 4:  $50,000/(1.05)4=$41,135.12 
























Appendix M:  Table 6 
Descriptive statistics 
Variable Statistic Subjects 
Gender  Percentage (Number)  
  Female  0% (0) 
  Male 100% (50) 
 
Age Mean (Std. Dev.) 
  Cases  62.90 yrs. (6.226 yrs.) 
  Controls  62.90 yrs. (5.991 yrs.) 
 
BMI Mean (Std. Dev.)  
  Cases  33.19 lbs. (6.006 lbs.) 





















Appendix N:  Table 7 
Variables in the Project 
MRSA positive on admission 
MRSA positive history 
MRSA positive on discharge 
Gender 
ASA score 
Length of preoperative stay 
Type of surgery  
Location of surgery  







Albumin level within 90 days 
Acute renal failure 
Current dialysis 
Chronic obstructive pulmonary disease 
Tranexamic acid administered 
SSI within 30 days 
SSI within 90 days 
Postoperative day of infection 














Appendix O:  Table 8 
Case and Control Result Summary 
Variable  Cases              Controls                Overall                Χ²                 p value 
MRSA admit + 100% (10) 2.5% (1) 22% (11)  44.318 
  .000 
MRSA hx +  50% (5) 2.5% (1) 12% (6) 17.093 
 .001 
MRSA d/c + 30% (3) 2.5% (1) 8% (4) 8.220 
 .022  
ASA score 
  1 0% (0) 2.5% (1) 2.0% (1)  
  2 0% (0)  27.5% (11) 22% (11) 
  3 100% (10) 67.5% (27) 74.0% (37) 
  4 0% (0) 2.5% (1) 2.0% (1)  4.392 
 .222 
Pre-op stay 100% (10) 100% (40) 100% (50) 
  
Surgery type 
  THA 50% (5) 50% (20) 50% (25) 
  TKA 50% (5) 50% (20) 50% (25)  .000 .637 
Surgery side 
  Right  70% (7) 70% (28) 70% (35)   
  Left  30% (3) 30% (12) 30% (15)  .000 
 .659 
Surgery length 
  1 to<2hrs  30% (3)  42.5% (17) 40% (20)   
  2 to>2hrs  70% (7) 57.5% (23) 60% (30)  .521 .365 
Wound class  100% (10) 100% (40) 100% (50)  
  
Preop abx 
  Cefazolin  30% (3) 85% (34) 74% (37) 
  Vancomycin  70% (7) 0% (0) 14% (7) 
  Clindamycin  0% (0) 15% (6) 12% (6)  32.770 
 .000 
Mupirocin  70% (7) 0% (0) 14% (7) 32.558 
 .000 
Postop abx 
  Cefazolin  30% (3) 82.5% (33) 72% (36) 
  Vancomycin  70% (7) 5% (2) 18% (9) 











  No 20% (2) 80% (32) 68% (34)  
  Diet 20% (2) 2.5% (1) 6.0% (3) 
  Oral  40% (4) 7.5% (3) 14% (7) 
  Insulin  20% (2) 10% (4) 12% (6) 15.021 
 .002  
Tobacco use  
  Never  10% (1) 0% (0) 2% (1) 
  w/in 2 weeks  20% (2) 22.5% (9) 2% (11) 
  w/out > 12 mo. 70% (7) 77.5% (31) 76% (38) 4.082 
  .130 
Albumin w/in 90d 100% (10) 90% (36) 92% (46) 1.087 
  .397 
Acute renal failure 100% (10) 100% (40) 100% (50) 
 
Current dialysis 100% (10) 100% (40) 100% (50) 
 
COPD  10% (1) 10% (4) 10% (5) .000 
 .742 
Tranexamic acid 40% (4) 0% (0) 8% (4) 17.391 
 .001 
SSI<30d  0% (0) 2.5% (1) 2% (1) .255 
 .800 
SSI 30-90d  0% (0) 2.5% (1) 2.0% (1) .255 
 .800 
POD of SSI 
  <30d  0 pod 10  
 
  30-90d  0 pod 82  
 
Depth of SSI 
  Superficial  0 0  
 
  Deep  0 0  
 
  Organ/space (joint) 0 2  
 
Site cultured 
  Right  0 2  
 
  Left  0 0  
 
Pathogen  none CNS (1) 
   Group B beta streptococcus (1) 
 
a. Cell count <5, computed for 2x2 table only.  
b. No statistics are computed, variable is a constant. 
 
 
